Gene · 6528
Papers4,585
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,585
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tyrosine Kinase Inhibitors for Radioactive Iodine Refractory Differentiated Thyroid Cancer. | Life (Basel) | 2023 | 38255638 | PubTator, text mining | PubMed |
| Per- and polyfluoroalkyl substances (PFAS) exposure might be a risk factor for thyroid cancer. | EBioMedicine | 2023 | 38251466 | PubTator, text mining | PubMed |
| Novel Therapies in Glioblastoma Treatment: Review of Glioblastoma; Current Treatment Options; and Novel Oncolytic Viral Therapies. | Med Sci (Basel) | 2023 | 38249077 | PubTator, text mining | PubMed |
| Investigating causal associations among gut microbiota, metabolites and autoimmune hypothyroidism: a univariable and multivariable Mendelian randomization study. | Front Immunol | 2023 | 38239342 | PubTator, text mining | PubMed |
| Discussion to: Association of timing of percutaneous left ventricular assist device insertion with outcomes in patients undergoing cardiac surgery. | JTCVS Open | 2023 | 38204658 | PubTator, text mining | PubMed |
| An Artificial Intelligence System for Optimizing Radioactive Iodine Therapy Dosimetry. | J Clin Med | 2023 | 38202124 | PubTator, text mining | PubMed |
| Iodine: a scoping review for Nordic Nutrition Recommendations 2023. | Food Nutr Res | 2023 | 38187800 | PubTator, text mining | PubMed |
| Oncolytic virotherapy in cancer treatment: challenges and optimization prospects. | Front Immunol | 2023 | 38169820 | PubTator, text mining | PubMed |
| The potential association of peripheral inflammatory biomarkers in patients with papillary thyroid cancer before radioiodine therapy to clinical outcomes. | Front Endocrinol (Lausanne) | 2023 | 38161980 | PubTator, text mining | PubMed |
| Clinical Benefit of Radioiodine Administration in a Rare Case of Iodine Avid Thyroid Carcinoma with No Secretion of Thyroglobulin. | World J Nucl Med | 2023 | 38152095 | PubTator, text mining | PubMed |
| Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs. | Front Pharmacol | 2023 | 38146457 | PubTator, text mining | PubMed |
| DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair. | Pharmaceutics | 2023 | 38140100 | PubTator, text mining | PubMed |
| Oncolytic Viruses in the Era of Omics, Computational Technologies, and Modeling: Thesis, Antithesis, and Synthesis. | Int J Mol Sci | 2023 | 38139207 | PubTator, text mining | PubMed |
| Intraplaque Neovascularization, CD68+ and iNOS2+ Macrophage Infiltrate Intensity Are Associated with Atherothrombosis and Intraplaque Hemorrhage in Severe Carotid Atherosclerosis. | Biomedicines | 2023 | 38137496 | PubTator, text mining | PubMed |
| Comparative Serum Proteome Profiling of Canine Benign Prostatic Hyperplasia before and after Castration. | Animals (Basel) | 2023 | 38136890 | PubTator, text mining | PubMed |
| Increased Thyroidal Activity on Routine FDG-PET/CT after Combination Immune Checkpoint Inhibition: Temporal Associations with Clinical and Biochemical Thyroiditis. | Cancers (Basel) | 2023 | 38136348 | PubTator, text mining | PubMed |
| The Role of Mesenchymal Stem Cells in Modulating the Breast Cancer Microenvironment. | Cell Transplant | 2023 | 38135917 | PubTator, text mining | PubMed |
| Evaluation of patients diagnosed with congenital hypothyroidism by newborn screening between 2011-2019 in Diyarbakir, Turkey. | Medicine (Baltimore) | 2023 | 38134076 | PubTator, text mining | PubMed |
| Structural Malformations in the Neonatal Rat Brain Accompany Developmental Exposure to Ammonium Perchlorate. | Toxics | 2023 | 38133428 | PubTator, text mining | PubMed |
| Survivin-Sodium Iodide Symporter Reporter as a Non-Invasive Diagnostic Marker to Differentiate Uterine Leiomyosarcoma from Leiomyoma. | Cells | 2023 | 38132150 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6528/papers?page=18